Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233946 · ClinicalTrials.gov registry record · NA
Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care
A NA study of Prevention Harmful Effects, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 871
- Enrollment target
- 5
- Study locations
NCT02233946 is a NA study of Prevention Harmful Effects that has completed, run by Boston Children's Hospital. The registered enrollment target is 871 participants. The trial reports 5 study locations across 1 state.
The verdict
NCT02233946, a NA study of Prevention Harmful Effects, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 871 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to assess the psychometric properties of a brief screening questionnaire for alcohol problems among 9- to 18-year-old patients in pediatricians' offices, and to pilot test a personalized, computer-facilitated brief intervention delivered on a tablet computer and by the provider based on screening results.
Conditions Studied
Interventions
- BEHAVIORAL computer-facilitated brief intervention
Study Locations (5)
Massachusetts
- Tufts Medical Center - Boston
- Boston Childrens Primary Care Center - Boston
- Longwood Pediatrics - Boston
- East Boston Neighborhood Health Center - East Boston
- Lexington Pediatrics - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 871 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233946
The ClinicalTrials.gov registry entry for NCT02233946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 871 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prevention Harmful Effects appearing as the primary indexed condition, and to 1 intervention - of which computer-facilitated brief intervention is the first listed.
NCT02233946 reports 5 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02233946 about?
NCT02233946 is a clinical study titled "Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care". The purpose of this study is to assess the psychometric properties of a brief screening questionnaire for alcohol problems among 9- to 18-year-old patients in pediatricians' offices, and to pilot test a personalized, computer-facilitated brief intervention delivered on a tablet computer and by the p...
What is the current status of trial NCT02233946?
This trial is currently completed. It is a NA study. The enrollment target is 871 participants. The study started on 2015-01. Estimated completion is 2018-05-31.
What conditions does trial NCT02233946 study?
This clinical trial studies the following conditions: Prevention Harmful Effects.
What interventions are being tested in trial NCT02233946?
The interventions under investigation include: computer-facilitated brief intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02233946?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02233946 being conducted?
This trial has 5 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.